Literature DB >> 24330785

Comparative Labeling of Equine and Ovine Multipotent Stromal Cells With Superparamagnetic Iron Oxide Particles for Magnetic Resonance Imaging In Vitro.

Henriette Jülke1, Christin Veit, Iris Ribitsch, Walter Brehm, Eberhard Ludewig, Uta Delling.   

Abstract

The purpose of this study was to evaluate the use of three different superparamagnetic iron oxide (SPIO) particles for labeling of ovine and equine bone marrow (BM)-derived multipotent stromal cells (MSCs) in vitro. MSCs were obtained from five adult sheep and horses, respectively. After three passages (p3), cells were labeled with either 1) Molday ION Rhodamine B, 2) Endorem, 3) Resovist, or 4) remained unlabeled as control. Labeling efficiency, marker retention, and long-term detectability in MRI until p7 were evaluated. Further, proliferation capacity and trilineage differentiation as indicators for potential impact on stromal cell characteristics were assessed. MSCs of both species were successfully labeled with all three SPIO products. A high, exclusively intracellular, iron uptake was achieved by Molday ION Rhodamine B only. Labeling with Resovist led to prominent extracellular iron presence; labeling with Endorem was less efficient. During MRI, all labeled cells showed strong hypointense signals, contrary to unlabeled controls. Resovist induced the largest areas of hypointense signals, followed by Molday ION Rhodamine B and Endorem. MRI signal detectability decreased from p4 to p7. Proliferation, adipogenic, and osteogenic differentiation potential were not reduced by cell labeling compared to unlabeled cells. Chondrogenic differentiation capacity decreased with increasing amount of iron associated with the cells. Among the three products, Resovist and Molday were identified as promising labeling agents. While Resovist achieved superior results in most of the assessed parameters, Molday ION Rhodamine B ensured intracellular iron uptake without extracellular SPIO complexes and consistent hypointense signals on MRI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24330785     DOI: 10.3727/096368913X675737

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

Review 1.  Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach.

Authors:  In K Cho; Silun Wang; Hui Mao; Anthony Ws Chan
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

2.  Viability, differentiation capacity, and detectability of super-paramagnetic iron oxide-labeled muscle precursor cells for magnetic-resonance imaging.

Authors:  Fahd Azzabi; Markus Rottmar; Virginija Jovaisaite; Markus Rudin; Tullio Sulser; Andreas Boss; Daniel Eberli
Journal:  Tissue Eng Part C Methods       Date:  2014-08-04       Impact factor: 3.056

3.  Evaluation of engraftment of superparamagnetic iron oxide-labeled mesenchymal stem cells using three-dimensional reconstruction of magnetic resonance imaging in photothrombotic cerebral infarction models of rats.

Authors:  Jaehyun Shim; Byung Kook Kwak; Jisung Jung; Serah Park
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 4.  Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do.

Authors:  Iris Ribitsch; Pedro M Baptista; Anna Lange-Consiglio; Luca Melotti; Marco Patruno; Florien Jenner; Eva Schnabl-Feichter; Luke C Dutton; David J Connolly; Frank G van Steenbeek; Jayesh Dudhia; Louis C Penning
Journal:  Front Bioeng Biotechnol       Date:  2020-08-13

5.  Longitudinal monitoring of stem cell grafts in vivo using magnetic resonance imaging with inducible maga as a genetic reporter.

Authors:  In K Cho; Sean P Moran; Ramesh Paudyal; Karolina Piotrowska-Nitsche; Pei-Hsun Cheng; Xiaodong Zhang; Hui Mao; Anthony W S Chan
Journal:  Theranostics       Date:  2014-07-27       Impact factor: 11.556

6.  Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions--a pilot study.

Authors:  Florian Geburek; Kathrin Mundle; Sabine Conrad; Maren Hellige; Ulrich Walliser; Hans T M van Schie; René van Weeren; Thomas Skutella; Peter M Stadler
Journal:  Stem Cell Res Ther       Date:  2016-02-01       Impact factor: 6.832

7.  Longitudinal Cell Tracking and Simultaneous Monitoring of Tissue Regeneration after Cell Treatment of Natural Tendon Disease by Low-Field Magnetic Resonance Imaging.

Authors:  Dagmar Berner; Walter Brehm; Kerstin Gerlach; Claudia Gittel; Julia Offhaus; Felicitas Paebst; Doreen Scharner; Janina Burk
Journal:  Stem Cells Int       Date:  2016-01-10       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.